Recent data investigating the role of Sox9 in PDA initiation suggest that ductal but also centroacinar cells (CACs) are more refractory to transformation mediated by a mutated Kras allele compared to acinar cells [5]. The gene discussed is KRAS; the disease is Patent ductus arteriosus.